Eric Topol talks with pioneering geneticist George Church about his many research interests, including his central role in developing CRISPR, a gene-editing tool that stands to revolutionize medicine. Medscape
Trabectome-phaco yields less refractive precision than phaco alone
FORT LAUDERDALE, Fla. — Combined Trabectome surgery and phacoemulsification yielded unforeseen refractive changes that were not predicted by current IOL calculation techniques, according to a scientific poster presented here.The retrospective study, presented by Douglas J. Rhee, MD, and colleagues at the American Glaucoma Society meeting, included 50 patients with primary open-angle glaucoma; 34 patients underwent combined phacoemulsification and Trabectome (NeoMedix) surgery, and 16 patients underwent phacoemulsification alone.
Medline: Five Things Healthcare Organizations Can Do to Improve Patient Safety Today
MUNDELEIN, Ill.–(BUSINESS WIRE)–During Patient Safety Awareness Week (March 13-19), Medline shares five things healthcare organizations can do to improve patient safety today.
Revisiting the Vicious Circle of Dry Eye Disease
Gain a better understanding of the pathophysiological mechanisms involved in meibomian gland dysfunction and its relationship to dry eye disease. The British Journal of Ophthalmology
Aerie reports $74.4 million net loss in 2015
Aerie Pharmaceuticals reported a GAAP net loss of $74.4 million, or $2.88 per share, in 2015, according to a company press release. In 2014, the GAAP net loss was $48.1 million, or $2 per share.
Clinton’s Health Plan Gets Mostly Passing Grades From Policy Experts
(MedPage Today) — But chances of passage “zero” without big change in Congress